For instance, as a novel anticancer drug, the main mechanism by which Britannin (Bri) inhibits the growth and proliferation of hepatoma cells is to over-activate AMPK/mTOR pathway-mediated autophagy to promote autophagic cell death [214]. This evidence concerns the gene MTOR and hepatocellular carcinoma.